Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 26Breast 10Thoracic 8Genitourinary 7Gynecologic 5Sarcoma 4Dermatologic 3CNS 3Other solid neoplasm 2Head & Neck 2Other 1Lymphoid 1Endocrine 1

Conditions

Obesity 11Polycystic Ovary Syndrome 4Overweight 2Endometrial Neoplasms 2Diabetes Mellitus 2Breast Neoplasms 2Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Periodontitis 1Neuritis 1Mucositis 1Metabolic Syndrome 1Insulin Resistance 1Hyperlipidemias 1Hematopoietic and Lymphoid System Neoplasm 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1Cancer-related Fatigue 1Bone Diseases 1

Interventions

Pentoxifylline 1Oxaliplatin 1Leucovorin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Colonic Neoplasms × Other × Clear all
NCT05590117 2022-10-21

Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer

Tanta University

Phase EARLY_PHASE1 Unknown
48 enrolled
GastrointestinalOther

Colonic Neoplasms, Neuritis, Colorectal Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡